Skip to content

Human Observatory Study

The Human Observatory: A Prospective Individual and Population-Level Study of Aging, Health, and Longevity

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07646782
Acronym
HOS
Enrollment
1000000
Registered
2026-06-15
Start date
2026-04-25
Completion date
2099-12-31
Last updated
2026-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Activities of Daily Living, Aging, All-cause Mortality, Cardiovascular Diseases, Cognitive Dysfunction, Dementia, Environmental Exposure, Frailty, Health Equity, Health Related Quality of Life, Life Expectancy, Metabolic Syndrome, Mortality, Musculoskeletal Disease, Neoplasms, Neurodegenerative Disease, Occupational Diseases, Physical Disability, Social Determinants of Health

Keywords

longevity, biological aging, causal inference, life expectancy, exposome, Environmental Health, Social Determinants, Genealogy, Family History, Human Family Tree, Population Health, Neighborhood Health, Geographic Health Disparities, Health Equity, Mortality Prediction, Biomarker Validation, Cardiopulmonary Exercise Testing, Body Composition, Preventive Medicine, Healthspan, Functional Decline, Centenarian, Space Medicine, Aerospace Medicine, World Model

Brief summary

The Human Observatory Study is a prospective observational and ecological surveillance study building a continuously-updating world model for human health, disease, and death at the individual and population level. Individual multi-system clinical data from enrolled participants are linked to a continuously-ingested ecological data infrastructure spanning environmental exposures, social determinants, genealogical and family history records, mortality data, and population health databases at geographic resolutions from home address to global scale and beyond. The resulting model generates individual screening recommendations informed by population-level causal estimates, and population-level causal forecasts anchored by present-timepoint individual clinical biology. This linkage creates a feedback architecture designed to improve both simultaneously.

Detailed description

Existing approaches to human health prediction face a structural limitation: individual clinical studies measure biology without capturing the environment, while population epidemiology captures the environment without individual biological ground truth. The Human Observatory Study resolves this by operating at both levels simultaneously through a linked dual-layer architecture. At the individual level, participants enrolled in the 100-Year Human Aging Study contribute comprehensive multi-system health measurements. This includes clinical, physiological, cognitive, behavioral, social, occupational, and environmental data collected at fixed and mobile clinical sites. These measurements provide the biological present timepoint that historical population data alone cannot supply. At the population level, the Observatory continuously ingests ecological data from public and private registries across multiple input domains. This includes air quality, water and chemical contaminants, wildfire and smoke exposure, altitude and terrain, climate, satellite earth observation, occupational and industrial exposure, mortality and vital statistics, demographics and social determinants, and clinical data networks at geographic resolutions from home address to global scale and beyond. This ecological layer captures the environmental and social causal structure of health and disease continuously and does not require individual enrollment. A foundational input domain is genealogy and family history. Health and disease run in families across generations. The Observatory is designed to build and continuously expand a linked genealogical database connecting living and historical individuals to their family health histories. Information is obtained from public genealogical records, death registries, family history self-report, and genetic data where available. The long-term vision is a genealogical infrastructure of sufficient depth and breadth to trace familial health patterns across the full recorded human family tree. Therefore connecting individual present-timepoint biology to multigenerational patterns of disease, longevity, and environmental exposure that no existing biobank or longitudinal study has attempted to capture at this scale. The linked architecture enables a feedback loop with two outputs: population-level causal estimates that inform individual screening recommendations, and individual clinical data that give population models a present biological anchor for prospective forecasting. The degree to which each input domain, alone and in combination, predicts health, disease, and death across geographic scales from neighborhood to global and beyond is the central scientific question the Observatory is designed to answer. The Observatory launches in Colorado, chosen as the founding site for its exceptional natural variation in altitude, wildfire smoke corridors, mining and industrial chemical geographies, and frontier-to-urban socioeconomic gradient all within a compact, well-characterized geography with established academic research infrastructure. Colorado proves the model. The architecture then replicates geographically, with each new location enriching the world model for every other. The long-term vision is global coverage and beyond. Every geography will contribute its environmental, social, and biological signal to a world model that gets more accurate with every geography studied, every participant enrolled, every dataset ingested, and every causal analysis conducted. The Human Observatory Study is conducted across all Longevity Metrics participation pathways, current and future: the Boulder fixed laboratory; all current and future fixed clinical sites; mobile screening units including the Health Ahead Bus; and an online participation pathway through which participants enroll and contribute structured data without in-person screening. Ecological data are ingested continuously from public and private registries independent of individual enrollment. All pathways operate under a single protocol with identical procedures, data management, informed consent, and safety standards. This study is one of four that compound into one system. The 100-Year Human Aging Study (NCT07563777) supplies the clinical data and validates what it means for health, disease, disability, and death. The Health Ahead Comparative Effectiveness Study (NCT07669168) moves the screening toward increasing automation and mobility while maintaining quality. The Longevity Metrics AI/ML Development Study (NCT pending approval) builds the models that make automation, prediction, and broad utilization possible, and returns each model's geographic residuals here. This study does with sociodemographic and environmental data what the 100-Year study does with clinical data, and defines the validated envelope within which each model's output is labeled.

Interventions

OTHERMulti-Domain Ecological and Clinical Data Linkage

Linkage of individual multi-system clinical health measurements to continuously-ingested ecological data from public and private registries spanning environmental, social, genealogical, and population health domains at geographic resolutions from home address to global scale and beyond. The linked dataset feeds a continuously-updating causal inference engine generating life expectancy estimates, disease cluster detection, individual screening recommendations, and population health intelligence.

Sponsors

Longevity Metrics, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Enrolled in the 100-Year Human Aging Study at any fixed or mobile clinical site; OR completion of online health screener with provision of geographic anchor data and consent.

Exclusion criteria

* Age under 18 years (current protocol; pediatric amendment planned).

Design outcomes

Primary

MeasureTime frameDescription
Geographic Disease Cluster and Outbreak DetectionFrom enrollment until death, assessed periodically, up to 100 yearsStatistically anomalous concentrations of incident disease, mortality spikes, or shared symptom patterns at neighborhood and community resolution.
Life Expectancy Estimates by GeographyFrom enrollment until death, assessed periodically, up to 100 yearsContinuously-updated life expectancy point estimates with credible intervals generated at individual, neighborhood, ZIP code, county, state, national, global, and beyond-earth scales using individual clinical data linked to population mortality records, environmental context, and ecological data.

Secondary

MeasureTime frameDescription
Incident Serious Health Events and Chronic DiseaseFrom enrollment until death, assessed periodically, up to 100 yearsNew diagnosis of myocardial infarction, stroke, cancer, dementia, heart failure, atrial fibrillation, sepsis, venous thromboembolism, COPD, chronic hypoxia, major fracture, type 2 diabetes, hypertension, chronic kidney disease, metabolic syndrome, or osteoporosis ascertained via periodic follow-up contact and health data network linkage.
Individual Screening Recommendation AccuracyFrom enrollment until death, assessed periodically, up to 100 yearsConcordance between population-level causal estimates used to generate individualized screening recommendations and actual individual health outcomes at longitudinal follow-up, assessed periodically as outcomes accrue.
Causal Effect Estimates for Modifiable ExposuresFrom enrollment until death, assessed periodically, up to 100 yearsEstimated attributable life-years gained or lost per unit change in modifiable environmental, occupational, and social exposures.
Geographic Variation in Disability-Free Life ExpectancyFrom enrollment until death, assessed periodically, up to 100 yearsDisability-free life expectancy stratified by geography, ascertained via the functional independence and disability survey instrument used across all three associated protocols.
Health Equity CharacterizationFrom enrollment until death, assessed periodically, up to 100 yearsLife expectancy gaps and chronic disease disparities stratified by geography, income, race and ethnicity, educational attainment, and rural-urban classification.
Population Biological Age AccelerationFrom enrollment until death, assessed periodically, up to 100 yearsMean difference between chronological age and biological age estimate for repeat-visit participants, stratified by geographic and demographic characteristics.
Human Tree of Life GrowthFrom enrollment until death, assessed periodically, up to 100 yearsTotal participants linked to genealogical record; multigenerational depth achieved; proportion of enrolled participants with identified biological relatives in the registry; total historical individuals linked across all genealogical databases.
Multi-Domain Predictor ModelingFrom enrollment until death, assessed periodically, up to 100 yearsAssessment of individual and composite clinical, biological, behavioral, environmental, social, occupational, genealogical, and geographic measurements as predictors of all-cause mortality, life expectancy, and incident serious disease at population scale; analyses evaluate which domains are independently predictive, which are redundant, and which combinations provide additive or synergistic predictive value.

Countries

United States

Contacts

CONTACTWilliam Brandenburg, MD
info@longevitymetrics.org13035010016
PRINCIPAL_INVESTIGATORWilliam Brandenburg, MD

Longevity Metrics

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 9, 2026